Rachel Dreyer BSc.(Hons), PhD

Postdoctoral Fellow in Medicine

Biographical Info

Dr Rachel Dreyer is a clinical research scientist and a visiting scholar at the Yale-New Haven Hospital Center for Outcomes Research and Evaluation (CORE). Dr Dreyer’s main areas of interests include examining sex and gender based differences in a range of vascular disorders including coronary and peripheral artery diseases.

She has a particular interest in post acute myocardial infarction (AMI) outcomes with a focus on pre hospital/hospital delays and performance measures (i.e. Door-to-Balloon time), sex based cardiac physiology/hemodynamics as well as an interest in cardiovascular health outcomes and health related quality of life utilizing both generic/disease specific measures.

Although Dr Dreyer’s research is inclusive of women of all ages, her time at CORE will build upon her interest in understanding why young women (i.e. <55 years) with heart disease have poorer outcomes. It will particularly focus on the VIRGO study (Variation In Recovery: Role of Gender on Outcomes of Young Acute Myocardial Infarction Patients), which endeavors to explain the three-fold higher mortality amongst young women who experience an AMI.

Prior to joining the CORE lab, Dr Dreyer completed her doctoral training at the University of Adelaide in South Australia, supported by the Australian Post Graduate Award. As part of her doctorate she played pivotal roles as the Australian coordinator for two international studies. Namely, the VIRGO project as mentioned above as well the PORTRAIT study (Patient centered Outcomes Related to Treatment practices in Peripheral Arterial disease: an International Trajectory).

Dr Dreyer’s postdoctoral term is supported by the prestigious American Australian Association Fellowship (Sir Keith Murdoch Fellow).


Education & Training

B.S.
University of Adelaide (Australia) (2007)
Ph.D.
University of Adelaide (Australia) (2013)

Edit Profile